SIK2 and breast carcinoma: While most reports suggest that SIK2 is an oncogenic marker, one study in Turkey claimed that SIK2 is a potential tumor suppressor in breast cancer (23); SIK2 expression was reportedly reduced in tumor tissues and breast cancer cell lines compared with that in normal counterparts.